These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study. Coppens JP, Cornu C, Lens E, Lamy M, Geubel A. Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491 [Abstract] [Full Text] [Related]
3. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. Perrillo RP, Regenstein FG, Peters MG, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC. Ann Intern Med; 1988 Jul 15; 109(2):95-100. PubMed ID: 3289433 [Abstract] [Full Text] [Related]
4. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study. Coppens JP, Cornu C, Lens E, Lamy M, Geubel AP. J Hepatol; 1990 Jul 15; 11 Suppl 1():S126-8. PubMed ID: 2079569 [Abstract] [Full Text] [Related]
5. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Lisker-Melman M, Webb D, Di Bisceglie AM, Kassianides C, Martin P, Rustgi V, Waggoner JG, Park Y, Hoofnagle JH. Ann Intern Med; 1989 Sep 15; 111(6):479-83. PubMed ID: 2774373 [Abstract] [Full Text] [Related]
6. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Ann Intern Med; 1991 Apr 15; 114(8):629-34. PubMed ID: 2003708 [Abstract] [Full Text] [Related]
7. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B. Hayashi PH, Beames MP, Kuhns MC, Hoofnagle JH, Di Bisceglie AM. Am J Gastroenterol; 1996 Nov 15; 91(11):2323-8. PubMed ID: 8931411 [Abstract] [Full Text] [Related]
8. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B. Di Bisceglie AM, Fong TL, Fried MW, Swain MG, Baker B, Korenman J, Bergasa NV, Waggoner JG, Park Y, Hoofnagle JH. Am J Gastroenterol; 1993 Nov 15; 88(11):1887-92. PubMed ID: 8237937 [Abstract] [Full Text] [Related]
9. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, Hepatitis Interventional Therapy Group. N Engl J Med; 1990 Aug 02; 323(5):295-301. PubMed ID: 2195346 [Abstract] [Full Text] [Related]
10. Pilot study of recombinant human alpha-interferon for chronic type B hepatitis. Dooley JS, Davis GL, Peters M, Waggoner JG, Goodman Z, Hoofnagle JH. Gastroenterology; 1986 Jan 02; 90(1):150-7. PubMed ID: 3940241 [Abstract] [Full Text] [Related]
11. Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects. Omata M, Imazeki F, Yokosuka O, Ito Y, Uchiumi K, Mori J, Okuda K. Gastroenterology; 1985 Apr 02; 88(4):870-80. PubMed ID: 3972231 [Abstract] [Full Text] [Related]
12. Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha. Teran JC, Mullen KD, Hoofnagle JH, McCullough AJ. Hepatology; 1994 Apr 02; 19(4):849-56. PubMed ID: 8138256 [Abstract] [Full Text] [Related]
13. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response. Brook MG, McDonald JA, Karayiannis P, Caruso L, Forster G, Harris JR, Thomas HC. Gut; 1989 Aug 02; 30(8):1116-22. PubMed ID: 2670693 [Abstract] [Full Text] [Related]
14. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM. Gastroenterology; 1995 Aug 02; 109(2):540-6. PubMed ID: 7615204 [Abstract] [Full Text] [Related]
15. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Lampertico P, Del Ninno E, Manzin A, Donato MF, Rumi MG, Lunghi G, Morabito A, Clementi M, Colombo M. Hepatology; 1997 Dec 02; 26(6):1621-5. PubMed ID: 9398007 [Abstract] [Full Text] [Related]
16. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Brunetto MR, Oliveri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, David E, Verme G, Bonino F. Hepatology; 1989 Aug 02; 10(2):198-202. PubMed ID: 2663695 [Abstract] [Full Text] [Related]
17. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA. Gastroenterology; 1984 Jan 02; 86(1):150-7. PubMed ID: 6196251 [Abstract] [Full Text] [Related]
18. Treatment of chronic hepatitis B with interferon alfa-2b. Müller R, Baumgarten R, Markus R, Schulz M, Wittenberg H, Hintsche-Kilger B, Fengler JD, Von Wussow P, Meisel H, Klein H. J Hepatol; 1990 Jan 02; 11 Suppl 1():S137-40. PubMed ID: 2079572 [Abstract] [Full Text] [Related]
19. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Barbera C, Bortolotti F, Crivellaro C, Coscia A, Zancan L, Cadrobbi P, Nebbia G, Pillan MN, Lepore L, Parrella T. Hepatology; 1994 Aug 02; 20(2):287-90. PubMed ID: 8045488 [Abstract] [Full Text] [Related]
20. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moreno A, García-Aguado J, Carreño V. Hepatology; 1991 Jun 02; 13(6):1035-9. PubMed ID: 2050319 [Abstract] [Full Text] [Related] Page: [Next] [New Search]